Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


If You Can't Beat 'Em … Hire 'Em? PhRMA Exec Is New GPhA CEO

This article was originally published in The Pink Sheet Daily

Executive Summary

Chip Davis still believes in innovation, but now must balance that with affordability in new role leading the generic association.


Related Content

GPhRMA? Generic Trade Group Picks Up Another Exec From Brand Association
REMS Abuse Legislation: GPhA and PhRMA Set To Battle Again
Biosimilars Forum: How Do You Create A Brand-Generic Coalition? Don’t Talk About Naming
PhRMA Will Pursue Future ‘Cures’ Without Castellani: CEO Retiring Jan. 1
GPhA’s Next CEO Will Face Political, Regulatory Headwinds
REMS And Generics: GPhA Needs Legislation, Continues Education
GPhA And Actavis Divorcing: Biosimilars Behind The Rift
Biosimilar Diplomacy By Other Means: GPhA CEO Calls Out Amgen Guest
GPhA's New CEO Ralph Neas Brings Health Reform Advocacy Experience
PhRMA Has Labor Support For Extended Biologics Exclusivity


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts